Literature DB >> 12885749

Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 1999: implications for primary prevention.

Wendy A Wattigney1, George A Mensah, Janet B Croft.   

Abstract

BACKGROUND: Atrial fibrillation, the most common sustained disturbance of heart rhythm, is associated with a 5-fold increase in the incidence of ischemic stroke. METHODS AND
RESULTS: The National Hospital Discharge Survey was used to estimate the annual number and prevalence of hospitalizations with atrial fibrillation among men and women 35 years of age or older. From 1985 through 1999, hospitalizations increased from 154 086 to 376 487 for a first-listed diagnosis and from 787 750 to 2 283 673 for any diagnosis. Prevalence was higher among successive age groups. Age-standardized prevalence was consistently higher among men than women. In 1999, essential hypertension, ischemic heart disease, congestive heart failure, and diabetes were prominent coexisting conditions. The number of male patients discharged home decreased from 77% to 63%, whereas the number of discharges to long-term care increased from 9% to 15%; the corresponding values for women were 72% to 56% and 15% to 23%. A slight increase in discharges to short-term care was indicated, whereas no trends were noted for in-hospital mortality.
CONCLUSIONS: Hospitalizations for atrial fibrillation have increased dramatically (2- to 3-fold) in recent years. The public health burden of atrial fibrillation is enormous and expected to continue to increase over the next decades. Primary prevention of atrial fibrillation must be recognized and pursued as a complementary management strategy for reducing cardiovascular morbidity and mortality.

Entities:  

Mesh:

Year:  2003        PMID: 12885749     DOI: 10.1161/01.CIR.0000083722.42033.0A

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  112 in total

Review 1.  Implication from randomized trials of rate and rhythm controls on management of patients with persistent atrial fibrillation.

Authors:  Vincent E Hagens; Dirk J Van Veldhuisen; Harry J G M Crijns; Isabelle C van Gelder
Journal:  Ann Noninvasive Electrocardiol       Date:  2006-04       Impact factor: 1.468

Review 2.  Prevention of heart failure in the elderly: when, where and how to begin?

Authors:  Bodh I Jugdutt
Journal:  Heart Fail Rev       Date:  2012-09       Impact factor: 4.214

Review 3.  Antithrombotic treatment in atrial fibrillation.

Authors:  G Y H Lip; C J Boos
Journal:  Heart       Date:  2005-09-13       Impact factor: 5.994

4.  Drivers of hospitalization for patients with atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).

Authors:  Benjamin A Steinberg; Sunghee Kim; Gregg C Fonarow; Laine Thomas; Jack Ansell; Peter R Kowey; Kenneth W Mahaffey; Bernard J Gersh; Elaine Hylek; Gerald Naccarelli; Alan S Go; James Reiffel; Paul Chang; Eric D Peterson; Jonathan P Piccini
Journal:  Am Heart J       Date:  2014-02-17       Impact factor: 4.749

Review 5.  Atrial fibrillation in congestive heart failure.

Authors:  Steven A Lubitz; Emelia J Benjamin; Patrick T Ellinor
Journal:  Heart Fail Clin       Date:  2010-04       Impact factor: 3.179

Review 6.  Rate versus rhythm control in patients with atrial fibrillation: what the trials really say.

Authors:  Harry J G M Crijns
Journal:  Drugs       Date:  2005       Impact factor: 9.546

7.  Effect of atrial tachyarrhythmia duration on percentage of time with atrial pacing in pacemaker patients with paroxysmal atrial fibrillation.

Authors:  Andreas Schuchert; Gaby Frost; Thomas Meinertz
Journal:  J Interv Card Electrophysiol       Date:  2004-10       Impact factor: 1.900

8.  An international survey of physician and patient understanding, perception, and attitudes to atrial fibrillation and its contribution to cardiovascular disease morbidity and mortality.

Authors:  Etienne Aliot; Günter Breithardt; Josep Brugada; John Camm; Gregory Y H Lip; Panos E Vardas; Markus Wagner
Journal:  Europace       Date:  2010-05       Impact factor: 5.214

9.  Molecular genetics of atrial fibrillation.

Authors:  Samir B Damani; Eric J Topol
Journal:  Genome Med       Date:  2009-05-22       Impact factor: 11.117

Review 10.  A combined role of calcium channel blockers and angiotensin receptor blockers in stroke prevention.

Authors:  Ji-Guang Wang
Journal:  Vasc Health Risk Manag       Date:  2009-08-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.